Shopping Cart
- Remove All
- Your shopping cart is currently empty
DAPTA (Adaptavir) is an inhibitor of CCR5, shows potent anti-HIV activities.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $47 | In Stock | |
5 mg | $89 | In Stock | |
10 mg | $155 | In Stock | |
25 mg | $297 | In Stock | |
50 mg | $443 | In Stock | |
100 mg | $639 | In Stock |
Description | DAPTA (Adaptavir) is an inhibitor of CCR5, shows potent anti-HIV activities. |
Targets&IC50 | Gp120 BaL/sCD4-CCR5:55 pM (IC50, in Cf2Th/synR5 cells), Gp120CM CM235/sCD4-CCR5:0.32 nM (IC50, in Cf2Th/synR5 cells) |
In vitro | D-Ala-peptide T-amide (DAPTA), or Peptide T, named for its high threonine content (ASTTTNYT), is a synthetic peptide comprised of eight amino acids (185-192) of the gp120 V2 region and functions as a viral entry inhibitor by targeting selectively CCR5.?The anti-HIV-1 activity of DAPTA was evaluated in M/M infected with R5 HIV-1 strains.?DAPTA at 10(-9) M inhibited HIV-1 replication in M/M by > 90%.?PCR analysis of viral cDNA in M/M showed that DAPTA blocks HIV entry and in this way prevents HIV-1 infection.?Moreover, DAPTA acts as a strong inhibitor and was more active than the non-peptidic CCR5 antagonist TAK-779 in inhibiting apoptosis (mediated by RS HIV-1 strains produced and released by infected M/M) on a neuroblastoma cell line[1] |
Alias | D-Ala-peptide T-amide, Adaptavir |
Molecular Weight | 856.88 |
Formula | C35H56N10O15 |
Cas No. | 106362-34-9 |
Smiles | C[C@@H](O)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@@H](C)N)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(N)=O |
Relative Density. | 1.415g/cm3 |
Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 10 mM | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.